Posts by: Larry Luxner

News

Prominent gynecologist Hugh S. Taylor is such a fan of the new endometriosis therapy Orilissa (elagolix) that, within 48 hours of its U.S. approval, he was already prescribing it for his patients — ... Read more

July 24, 2018

FDA Approves AbbVie’s Orilissa to Treat Moderate to Severe Endometriosis Pain

News

Orilissa (elagolix) has won U.S. regulatory approval as the first oral therapy in a decade for moderate to severe pain linked to endometriosis — a disease that plagues 10 percent of ... Read more

June 23, 2017June 23, 2017

Citizen Endo’s Goal: 10,000 Women Using Its Mobile App to Track Endometriosis by 2018

News

Endometriosis — an illness that causes infertility, cramping and severe menstrual pain — is more common than either breast cancer or diabetes. Yet, unlike those two diseases, endometriosis is still ... Read more